CN111558031A - 一种纯植物多功能型眼睛专用营养液及其制备方法 - Google Patents
一种纯植物多功能型眼睛专用营养液及其制备方法 Download PDFInfo
- Publication number
- CN111558031A CN111558031A CN202010404033.8A CN202010404033A CN111558031A CN 111558031 A CN111558031 A CN 111558031A CN 202010404033 A CN202010404033 A CN 202010404033A CN 111558031 A CN111558031 A CN 111558031A
- Authority
- CN
- China
- Prior art keywords
- percent
- peptide
- root
- nutrient solution
- eye
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 58
- 241000196324 Embryophyta Species 0.000 claims abstract description 56
- 239000000243 solution Substances 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 241000251511 Holothuroidea Species 0.000 claims abstract description 13
- 240000004371 Panax ginseng Species 0.000 claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 244000302512 Momordica charantia Species 0.000 claims abstract description 12
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 12
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 10
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 9
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 9
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 9
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 9
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 9
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 9
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 9
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 9
- 244000112814 pipewort Species 0.000 claims abstract description 9
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 8
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 8
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 8
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 8
- 244000042430 Rhodiola rosea Species 0.000 claims abstract description 8
- 235000003713 Rhodiola rosea Nutrition 0.000 claims abstract description 8
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 7
- 244000081426 Ranunculus ficaria Species 0.000 claims abstract description 7
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 claims abstract description 6
- 235000006533 astragalus Nutrition 0.000 claims abstract description 3
- 241000304195 Salvia miltiorrhiza Species 0.000 claims abstract 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 19
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 11
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims description 11
- 229940116229 borneol Drugs 0.000 claims description 11
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims description 11
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims description 11
- 210000000582 semen Anatomy 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 9
- 229960002685 biotin Drugs 0.000 claims description 9
- 235000020958 biotin Nutrition 0.000 claims description 9
- 239000011616 biotin Substances 0.000 claims description 9
- 229960003080 taurine Drugs 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241001412627 Adenophora liliifolia Species 0.000 claims description 8
- 240000008365 Celosia argentea Species 0.000 claims description 8
- 235000000722 Celosia argentea Nutrition 0.000 claims description 8
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 8
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims description 8
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 8
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 8
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 8
- 240000000249 Morus alba Species 0.000 claims description 8
- 235000008708 Morus alba Nutrition 0.000 claims description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 6
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 claims description 6
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims description 6
- 229940107666 astragalus root Drugs 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229920001184 polypeptide Polymers 0.000 claims description 6
- 235000021283 resveratrol Nutrition 0.000 claims description 6
- 229940016667 resveratrol Drugs 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 244000061520 Angelica archangelica Species 0.000 claims description 5
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 5
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 4
- 229930003537 Vitamin B3 Natural products 0.000 claims description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims description 4
- 239000011708 vitamin B3 Substances 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241000217407 Margaritifera Species 0.000 claims description 3
- 240000007164 Salvia officinalis Species 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 3
- 241000045403 Astragalus propinquus Species 0.000 claims description 2
- 235000017276 Salvia Nutrition 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 230000004379 myopia Effects 0.000 abstract description 13
- 208000001491 myopia Diseases 0.000 abstract description 13
- 230000005855 radiation Effects 0.000 abstract description 8
- 230000004436 pseudomyopia Effects 0.000 abstract description 7
- 208000003251 Pruritus Diseases 0.000 abstract description 6
- 230000007803 itching Effects 0.000 abstract description 6
- 208000003464 asthenopia Diseases 0.000 abstract description 5
- 230000006872 improvement Effects 0.000 abstract description 5
- 206010013774 Dry eye Diseases 0.000 abstract description 4
- 206010023644 Lacrimation increased Diseases 0.000 abstract description 4
- 238000012937 correction Methods 0.000 abstract description 4
- 239000003889 eye drop Substances 0.000 abstract description 4
- 229940012356 eye drops Drugs 0.000 abstract description 4
- 230000004317 lacrimation Effects 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 4
- 230000009978 visual deterioration Effects 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 19
- 230000006870 function Effects 0.000 description 16
- 230000004438 eyesight Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 230000005670 electromagnetic radiation Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 208000002177 Cataract Diseases 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 208000030533 eye disease Diseases 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000000554 physical therapy Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 244000132619 red sage Species 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 1
- 235000001258 Cinchona calisaya Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010015988 Eyelid infection Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000010927 Mucositis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960000948 quinine Drugs 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 235000005412 red sage Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 208000005494 xerophthalmia Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/342—Adenophora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Emergency Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及外用保健品技术领域,且公开了一种纯植物多功能型眼睛专用营养液,包括以下原料组成:当归肽、人参肽、海参肽、苦瓜肽、黄芪、红景天、鱼腥草、桃仁、红花、葛根、沙参、玄参、丹参、酒大黄、谷精草和珍珠母。该纯植物多功能型眼睛专用营养液及其制备方法,原料部分取之植物肽,部分取之天然植物中药,部分取之强营养素,故无任何副作用,少年、青年、中年和老年皆可使用,并对假性近视和遗传性近视以及蓝光辐射或用眼过度造成的视觉疲劳、视力下降、眼睛干、涩、痒、痛、酸和流泪现象均有较明显的改善作用,同时避免了长期使用含有化学成分的滴眼液所造成的副作用,如配合二类近视矫正仪器或者眼睛按摩仪器使用效果更好。
Description
技术领域
本发明涉及外用保健品技术领域,具体为一种纯植物多功能型眼睛专用 营养液及其制备方法。
背景技术
眼睛俗称心灵的窗户,被认为是除了生命之外人体的最重要的器官之一, 然而随着电子用品特别是电脑、手机的开发应用,使人们在工作、学习、娱 乐等诸多领域越来越需要依赖的工具,早在2009年的时候,手机辐射对人体 的危害就被来自全球14个国家的31名科学家所组成的世界癌症研究所确定 为2B级致癌物,其中特别是对眼睛的辐射所造成的危害更加直接,所以对于 眼睛的保护以及近视眼的预防和改善,已经成为我国人民迫不及待需要解决 的问题。
目前人们多采用的是化学物质所做的滴眼液,或者单纯以生理盐水做成 的洗眼液,在近视眼的预防和治疗中,最常见的激光手术和使用二类医疗器 械矫正,这些手术要么成本高昂,要么有副作用,要么效果较差。
植物多肽液体眼膜,是一种以常用中药肽和植物性中药加强营养素精制 而成的眼睛专用营养液,针对不同年龄段和不同眼睛亚健康或者眼睛疾病的 前期症状,都有不同的类型及配方,但其中只具有特别的营养功效,不具有 理疗功效,特别是不具有治疗功效,故而提出一种纯植物多功能型眼睛专用 营养液及其制备方法来解决上述所提出的问题。
发明内容
(一)解决的技术问题
针对现有技术的不足,本发明提供了一种纯植物多功能型眼睛专用营养 液及其制备方法,具备眼睛视力保护和假性近视与遗传性近视改善及预防蓝 光辐射、缓解视觉疲劳功效等优点,解决了现有的眼睛专用营养液,针对不 同年龄段和不同眼睛亚健康或者眼睛疾病的前期症状,都有不同的类型及配 方,但其中只具有特别的营养功效,不具有理疗功效,特别是不具有治疗功 效的问题。
(二)技术方案
为实现上述具备眼睛视力保护和假性近视与遗传性近视改善及预防蓝光 辐射、缓解视觉疲劳功效等目的,本发明提供如下技术方案:一种纯植物多 功能型眼睛专用营养液,包括以下重量份数配比的原料:当归肽1.5%-1%、人 参肽0.5-1%、海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪9%-5%、红景天6%-7%、 鱼腥草5%-4%、桃仁4%-5%、红花5%-6%、葛根4%-5%、沙参2%-3%、玄参3%-2%、 丹参5%-7%、酒大黄2%-3%、谷精草4%-5%、珍珠母3%-5%、青葙子3%-2%、桑 叶4%-5%、淮菊花5%-2%、薄荷6%-3%、冰片5%-2%、决明子3%-4%、β-胡萝 卜素3%-4%、叶黄素酯5%-3%、牛磺酸4%-5%、维生素B22%-3%、生物素3%-2%、 维生素B31%-2%和白藜芦醇1%-2%。
优选的,包括以下重量份数配比的原料:当归肽1.5%-1%、人参肽0.5-1%、 海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪9%-5%、红景天6%-7%、鱼腥草5%-4%、 桃仁4%-5%、红花5%-6%、葛根4%-5%、沙参2%-3%、玄参3%-2%、丹参5%-7%、 酒大黄2%-3%、谷精草4%-5%、珍珠母3%-5%、青葙子3%-2%、桑叶4%-5%、淮 菊花5%-2%、薄荷6%-3%、冰片5%-2%、决明子3%-4%、β-胡萝卜素3%-4%、 叶黄素酯5%-3%、牛磺酸4%-5%、维生素B22%-3%、生物素3%-2%、维生素 B31%-2%和白藜芦醇1%-2%。
优选的,包括以下重量份数配比的原料:当归肽1.5%-1%、人参肽0.5-1%、 海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪12%、红景天6%、鱼腥草6%、桃仁 5%、红花5%、葛根5%、沙参2%、玄参3%、丹参5%、酒大黄2%、谷精草3%、 珍珠母2%、青葙子2%、桑叶4%、淮菊花5%、薄荷6%、冰片0.5%、决明子3%、 β-胡萝卜素3%、叶黄素酯5%、牛磺酸4%、维生素B2 2%、生物素3%、维生 素B31%和白藜芦醇2%。
本发明一种纯植物多功能型眼睛专用营养液中各种原料的功效为:
当归肽:是中药当归制成的一种小分子植物蛋白原料,具有活血通经、 抗电磁辐射作用。
人参肽:是用中药人参制成的一种小分子植物蛋白原料,具有提高免疫、 抗电磁辐射、抗癌等作用。
海参肽:是用深海生物海参制成的一种小分子动物蛋白原料,富含18种 氨基酸、且不含胆固醇,故有较好的抗辐射和提高免疫力的作用。
苦瓜肽:含有17种人体必须的氨基酸和生物碱类物质奎宁,具有消炎退 热、清心明目作用。
黄芪:植物类中药,具有抗菌托毒、排脓生肌、加强毛细血管抵抗力的 作用。
红景天:植物类中药,具有保护黏膜组织,抗病毒、提高免疫力调节神 经系统、抗拒电磁辐射作用。
鱼腥草:植物类中药,具有清热解毒,抗拒电磁辐射作用。
桃仁:植物类中药,具有通经活血、润肠通便作用。
红花:植物类中药,具有活血通经、祛瘀止痛的作用。
葛根:植物类中药,具有解肌退热、生津止渴和改善微循环的作用。
沙参:植物类中药,具有养阴清热、益胃生津、降低体温的作用。
玄参:植物类中药,具有清热凉血、滋阴降火和解毒作用。
丹参:植物类中药,具有活血化瘀、凉血养血、安神。
酒大黄:植物类中药,具有攻积导滞、泻火凉血和逐瘀通经的作用。
谷精草:植物类中药,对因风热之邪引发的眼睛发红、灼热、眼屎过多、 流泪、眼睛干涩,具有效果。
珍珠母:植物类中药,具有平肝潜阳、泻火明目的作用。
青葙子:植物类中药,具有祛风止痒、清热燥湿、散风明目作用。
桑叶:植物类中药,具有凉血止血、疏风散热、清肝明目作用。
淮菊花:植物类中药,具有清热解毒、疏散风热、清肝明目作用。
薄荷:植物类中药,具有疏肝解郁、醒脑提神和改善微循环作用。
冰片:植物类中药,具有开窍醒神、清热解毒作用。
决明子:植物类中药,具有平肝明目、润肠通便作用。
β-胡萝卜素:对上皮细胞的合成有好处,可预防暗视力的发生。
牛磺酸:可增加红细胞膜的稳定性,并有镇静、镇痛和消炎作用。
维生素B2:又称核黄素,具有预防和缓解皮肤黏膜炎症的作用,对口角 炎、睑缘炎、结膜炎均有改善作用。
生物素:又称维生素B7,主要功能治疗视力下降,夜盲症,缓解干眼综 合症。
维生素B3:又称烟酸,具有扩张毛细血管,改善外周血液循环的作用, 可增强人体的免疫力,促进免疫细胞生成。
白藜芦醇:能中和自由基对人体的损害,激活酶,促进肌肉及其它身体 组织的线粒体数量增加。
本发明要解决的另一技术问题是提供一种纯植物多功能型眼睛专用营养 液的制备方法,包括以下步骤:
1)按比例将黄芪、红景天、鱼腥草、桃仁、红花、葛根、沙参、玄参、 丹参、酒大黄、谷精草、珍珠母、青葙子、桑叶、淮菊花、薄荷和决明子混 合后,加15倍量(重量百分比)的过滤后纯净水、煎熬、过滤得滤渣和滤液;
2)将(1)所得滤液使用蒸馏提取方法,获得富含植物甾醇和植物多肽 类物质的蒸馏水;
3)按照所需比例分别取叶黄素酯、牛磺酸、生物素、维生素B3和当归 肽、人参肽、海参肽、苦瓜肽,混合后放入(2)所得的蒸馏水中,用均质 机搅拌均匀,制得混合液(3);
4)用55℃的高度粮食酒,将冰片化成液体,再将此液体倒入(3)所得 的混合液中,搅拌均匀后灌装,即可制得上述纯植物多功能型眼睛专用营养 液。
(三)有益效果
与现有技术相比,本发明提供了一种纯植物多功能型眼睛专用营养液及 其制备方法,具备以下有益效果:
该纯植物多功能型眼睛专用营养液及其制备方法,原料部分取之植物肽, 部分取之天然植物中药,部分取之强营养素,故无任何副作用,少年、青年、 中年和老年皆可使用,并对假性近视和遗传性近视以及蓝光辐射或用眼过度 造成的视觉疲劳、视力下降、眼睛干、涩、痒、痛、酸和流泪现象均有较明 显的改善作用,同时避免了长期使用含有化学成分的滴眼液所造成的副作用, 如配合二类近视矫正仪器或者眼睛按摩仪器使用效果更好。
具体实施方式
下面将结合本发明的实施例,对本发明实施例中的技术方案进行清楚、 完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全 部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造 性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
实施例一:
一种纯植物多功能型眼睛专用营养液,包括以下重量份数配比的原料: 归肽1.5%-1%、人参肽0.5-1%、海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪9%-5%、 红景天6%-7%、鱼腥草5%-4%、桃仁4%-5%、红花5%-6%、葛根4%-5%、沙参 2%-3%、玄参3%-2%、丹参5%-7%、酒大黄2%-3%、谷精草4%-5%、珍珠母3%-5%、 青葙子3%-2%、桑叶4%-5%、淮菊花5%-2%、薄荷6%-3%、冰片5%-2%、决明子 3%-4%、β-胡萝卜素3%-4%、叶黄素酯5%-3%、牛磺酸4%-5%、维生素B22%-3%、 生物素3%-2%、维生素B31%-2%和白藜芦醇1%-2%。
一种纯植物多功能型眼睛专用营养液的制备方法,包括以下步骤:
1)按比例将黄芪、红景天、鱼腥草、桃仁、红花、葛根、沙参、玄参、 丹参、酒大黄、谷精草、珍珠母、青葙子、桑叶、淮菊花、薄荷和决明子混 合后,加15倍量(重量百分比)的过滤后纯净水、煎熬、过滤得滤渣和滤液;
2)将(1)所得滤液使用蒸馏提取方法,获得富含植物甾醇和植物多肽 类物质的蒸馏水;
3)按照所需比例分别取叶黄素酯、牛磺酸、生物素、维生素B3和当归 肽、人参肽、海参肽、苦瓜肽,混合后放入(2)所得的蒸馏水中,用均质 机搅拌均匀,制得混合液(3);
4)用55℃的高度粮食酒,将冰片化成液体,再将此液体倒入(3)所得 的混合液中,搅拌均匀后灌装,即可制得上述纯植物多功能型眼睛专用营养 液。
实验例:按实施例1所制备的纯植物多功能型眼睛专用营养液进行实验。
刘某某,男30岁,左眼近视250度,右眼230度,分析近视原因与遗传 无关,故属于假性近视,至开始使用按实施例1所制备的植物多肽液体眼膜 时,已经近视16年时间,使用按实施例1所制备的植物多肽液体眼膜100天 后,左眼近视下降至146度,右眼下降至100度,效果明显。
胡某某,女,39岁(白领),由于长期过度使用电脑、手机工作,导致眼 睛经常处于干、涩、痒、痛状态,经医院建议点×××品牌和×××品牌眼 药,均无根本好转,后经人介绍使用“纯植物多功能型眼睛专用营养液”每 天3-5次,每次12-16秒钟,连续45天后,干、涩、痒、痛现象全部消除, 视觉也同时有较好改善。
叶某某,男,由于白内障左眼做完手术35天左右,右眼由于白内障不成 熟,无法手术,但视力下降严重至0.5左右,后开始使用“纯植物多功能型 眼睛专用营养液”,每天五次,早晚各一次,每餐饭后各一次,连续使用60 天后,右眼视力恢复到了1.0,白内障消失率高达90%,左眼视力也有较好恢 复。
本发明的有益效果是:该纯植物多功能型眼睛专用营养液及其制备方法, 原料部分取之植物肽,部分取之天然植物中药,部分取之强营养素,故无任 何副作用,少年、青年、中年和老年皆可使用,并对假性近视和遗传性近视 以及蓝光辐射或用眼过度造成的视觉疲劳、视力下降、眼睛干、涩、痒、痛、 酸和流泪现象均有较明显的改善作用,同时避免了长期使用含有化学成分的 滴眼液所造成的副作用,如配合二类近视矫正仪器或者眼睛按摩仪器使用效 果更好,解决了现有的眼睛专用营养液,针对不同年龄段和不同眼睛亚健康或者眼睛疾病的前期症状,都有不同的类型及配方,但其中只具有特别的营 养功效,不具有理疗功效,特别是不具有治疗功效的问题。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而 言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行 多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限 定。
Claims (4)
1.一种纯植物多功能型眼睛专用营养液,其特征在于,包括以下重量份数配比的原料:当归肽1.5%-1%、人参肽0.5-1%、海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪9%-5%、红景天6%-7%、鱼腥草5%-4%、桃仁4%-5%、红花5%-6%、葛根4%-5%、沙参2%-3%、玄参3%-2%、丹参5%-7%、酒大黄2%-3%、谷精草4%-5%、珍珠母3%-5%、青葙子3%-2%、桑叶4%-5%、淮菊花5%-2%、薄荷6%-3%、冰片5%-2%、决明子3%-4%、β-胡萝卜素3%-4%、叶黄素酯5%-3%、牛磺酸4%-5%、维生素B22%-3%、生物素3%-2%、维生素B31%-2%和白藜芦醇1%-2%。
2.根据权利要求1所述的一种纯植物多功能型眼睛专用营养液,其特征在于,包括以下重量份数配比的原料:当归肽1.5%-1%、人参肽0.5-1%、海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪9%-5%、红景天6%-7%、鱼腥草5%-4%、桃仁4%-5%、红花5%-6%、葛根4%-5%、沙参2%-3%、玄参3%-2%、丹参5%-7%、酒大黄2%-3%、谷精草4%-5%、珍珠母3%-5%、青葙子3%-2%、桑叶4%-5%、淮菊花5%-2%、薄荷6%-3%、冰片5%-2%、决明子3%-4%、β-胡萝卜素3%-4%、叶黄素酯5%-3%、牛磺酸4%-5%、维生素B22%-3%、生物素3%-2%、维生素B31%-2%和白藜芦醇1%-2%。
3.根据权利要求1所述的一种纯植物多功能型眼睛专用营养液,其特征在于,包括以下重量份数配比的原料:当归肽1.5%-1%、人参肽0.5-1%、海参肽0.5%-1%、苦瓜肽0.5%-1%、黄芪12%、红景天6%、鱼腥草6%、桃仁5%、红花5%、葛根5%、沙参2%、玄参3%、丹参5%、酒大黄2%、谷精草3%、珍珠母2%、青葙子2%、桑叶4%、淮菊花5%、薄荷6%、冰片0.5%、决明子3%、β-胡萝卜素3%、叶黄素酯5%、牛磺酸4%、维生素B2 2%、生物素3%、维生素B31%和白藜芦醇2%。
4.一种纯植物多功能型眼睛专用营养液的制备方法,其特征在于,包括以下步骤:
1)按比例将黄芪、红景天、鱼腥草、桃仁、红花、葛根、沙参、玄参、丹参、酒大黄、谷精草、珍珠母、青葙子、桑叶、淮菊花、薄荷和决明子混合后,加15倍量(重量百分比)的过滤后纯净水、煎熬、过滤得滤渣和滤液;
2)将(1)所得滤液使用蒸馏提取方法,获得富含植物甾醇和植物多肽类物质的蒸馏水;
3)按照所需比例分别取叶黄素酯、牛磺酸、生物素、维生素B3和当归肽、人参肽、海参肽、苦瓜肽,混合后放入(2)所得的蒸馏水中,用均质机搅拌均匀,制得混合液(3);
4)用55℃的高度粮食酒,将冰片化成液体,再将此液体倒入(3)所得的混合液中,搅拌均匀后灌装,即可制得上述纯植物多功能型眼睛专用营养液。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404033.8A CN111558031B (zh) | 2020-05-13 | 2020-05-13 | 一种纯植物多功能型眼睛专用营养液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010404033.8A CN111558031B (zh) | 2020-05-13 | 2020-05-13 | 一种纯植物多功能型眼睛专用营养液及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111558031A true CN111558031A (zh) | 2020-08-21 |
CN111558031B CN111558031B (zh) | 2023-10-27 |
Family
ID=72070987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010404033.8A Active CN111558031B (zh) | 2020-05-13 | 2020-05-13 | 一种纯植物多功能型眼睛专用营养液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111558031B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114366775A (zh) * | 2020-12-07 | 2022-04-19 | 慧眸国际生物科技(广东)有限公司 | 一种护目营养液 |
CN115779024A (zh) * | 2022-12-01 | 2023-03-14 | 成都爱佳眼科技有限公司 | 一种蓝莓叶黄素酯泡腾片及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031420A (zh) * | 2015-08-20 | 2015-11-11 | 孔青 | 一种用于护理糖尿病的中药制剂及制备方法 |
CN105769930A (zh) * | 2016-03-02 | 2016-07-20 | 威海康博尔生物药业有限公司 | 自血活化回输与微生态制剂和纳米中药的组合 |
CN107875289A (zh) * | 2017-06-21 | 2018-04-06 | 苏州雅致堂草本科技有限公司 | 一种保护视力的纯中药水凝胶护眼贴膜的制备方法 |
JP2018193357A (ja) * | 2017-10-31 | 2018-12-06 | 株式会社坪田ラボ | 近視予防用組成物及び機能性食品 |
CN110478442A (zh) * | 2019-08-28 | 2019-11-22 | 苏州焦宜姗建材科技有限公司 | 一种多功能眼药水及其制备方法 |
-
2020
- 2020-05-13 CN CN202010404033.8A patent/CN111558031B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105031420A (zh) * | 2015-08-20 | 2015-11-11 | 孔青 | 一种用于护理糖尿病的中药制剂及制备方法 |
CN105769930A (zh) * | 2016-03-02 | 2016-07-20 | 威海康博尔生物药业有限公司 | 自血活化回输与微生态制剂和纳米中药的组合 |
CN107875289A (zh) * | 2017-06-21 | 2018-04-06 | 苏州雅致堂草本科技有限公司 | 一种保护视力的纯中药水凝胶护眼贴膜的制备方法 |
JP2018193357A (ja) * | 2017-10-31 | 2018-12-06 | 株式会社坪田ラボ | 近視予防用組成物及び機能性食品 |
CN110478442A (zh) * | 2019-08-28 | 2019-11-22 | 苏州焦宜姗建材科技有限公司 | 一种多功能眼药水及其制备方法 |
Non-Patent Citations (2)
Title |
---|
JISU KIM等: "Ginseng for an eye: effects of ginseng on ocular diseases" * |
徐建玲;: "综合治疗中小学生近视的疗效观察" * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114366775A (zh) * | 2020-12-07 | 2022-04-19 | 慧眸国际生物科技(广东)有限公司 | 一种护目营养液 |
CN115779024A (zh) * | 2022-12-01 | 2023-03-14 | 成都爱佳眼科技有限公司 | 一种蓝莓叶黄素酯泡腾片及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN111558031B (zh) | 2023-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1051237C (zh) | 治疗癫痫病的药物 | |
CN101297889B (zh) | 治疗口蹄疫的中药制剂及其制备方法 | |
CN111558031A (zh) | 一种纯植物多功能型眼睛专用营养液及其制备方法 | |
CN1066945C (zh) | 明目中药剂及其生产方法 | |
CN100364593C (zh) | 一种提高视力保护眼睛的口服液 | |
CN101574446A (zh) | 一种治疗急性膀胱炎的中药 | |
CN101843694A (zh) | 一种治疗慢性肝炎的中药 | |
CN103463464B (zh) | 一种对糖尿病具有治疗作用的保健药酒 | |
CN102416145B (zh) | 一种治疗月经失调的中药组合物 | |
CN104971304A (zh) | 一种用于治疗干眼症的药物 | |
CN102793848B (zh) | 一种治疗夜盲的中药散剂 | |
CN104547934A (zh) | 一种治疗电光性眼炎的药物制剂及其制备方法 | |
CN104800389A (zh) | 一种治疗湿疹的外用药水 | |
CN102805800B (zh) | 一种治疗神经性皮炎的中药组合物 | |
CN109464517A (zh) | 清热解毒儿科外用按摩软膏配方、制备软膏的方法及应用 | |
CN105125708B (zh) | 一种用于鼻炎的药物组合物及其制备方法 | |
CN101057922A (zh) | 一种治疗白癜风病的中药制剂 | |
CN105194427A (zh) | 一种治疗干眼症的中药组合物及其制备方法 | |
CN1201811C (zh) | 一种治疗近视眼的中药组合物及制法 | |
CN104436076A (zh) | 一种用于治疗电光性眼炎的组合物及其应用 | |
CN103908508B (zh) | 一种脚气康复药剂 | |
CN110787237B (zh) | 一种有效治疗腓肠肌痉挛的中药组合物及其制备方法和应用 | |
CN101229224A (zh) | 一种治疗白癜风的中药软膏制剂及其制备方法 | |
CN105560837A (zh) | 治疗皮肤损伤的药物及其制备方法 | |
CN104491729A (zh) | 一种用于治疗电光眼的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230927 Address after: 18 / F, West building, 2218 Hunan Road, Pudong New Area, Shanghai, 200120 Applicant after: Shanghai Liangyan Biotechnology Co.,Ltd. Address before: No. 361 Huanghe Road, Demonstration Zone, Jiaozuo City, Henan Province, 454150 (formerly located in the northeast corner of the courtyard of Jiaozuo Pukun Machinery Manufacturing Co., Ltd.) Applicant before: Henan Zhuoyi Food Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |